Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.
Idahl, Annika
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort. [electronic resource] - International journal of cancer 10 2020 - 2042-2052 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0215
10.1002/ijc.32999 doi
Adult
Aged
Aged, 80 and over
Biomarkers--blood
Carcinoma, Ovarian Epithelial--blood
Case-Control Studies
Chlamydia Infections--blood
Chlamydia trachomatis--pathogenicity
Female
Human papillomavirus 16--pathogenicity
Humans
Middle Aged
Mycoplasma genitalium--pathogenicity
Ovarian Neoplasms--blood
Papillomavirus Infections--blood
Prospective Studies
Risk
Risk Factors
Sexually Transmitted Diseases--blood
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort. [electronic resource] - International journal of cancer 10 2020 - 2042-2052 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0215
10.1002/ijc.32999 doi
Adult
Aged
Aged, 80 and over
Biomarkers--blood
Carcinoma, Ovarian Epithelial--blood
Case-Control Studies
Chlamydia Infections--blood
Chlamydia trachomatis--pathogenicity
Female
Human papillomavirus 16--pathogenicity
Humans
Middle Aged
Mycoplasma genitalium--pathogenicity
Ovarian Neoplasms--blood
Papillomavirus Infections--blood
Prospective Studies
Risk
Risk Factors
Sexually Transmitted Diseases--blood